Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-431-5 | CAS number: 470-82-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- Between 22 September and 26 October 1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- To address toxicological endpoints as part of the REACH registration of Cineole (Target Substance) it is proposed to read-across to Clarycet (Source Substance). The use of read-across works within the spirit of REACH and the stated aim of the legislation to reduce animal testing where possible. The Target Substance and Source Substance have been characterised in using the categories and databases present in the OECD (Q)SAR Toolbox. From the profile, it can be seen that the two substances share structural similarities and also "mechanistic action" similarities which are both general and endpoint specific. Therefore read-across is justified.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Tetrahydro-4-methyl-2-propyl-2H-pyran-4-yl acetate
- IUPAC Name:
- Tetrahydro-4-methyl-2-propyl-2H-pyran-4-yl acetate
- Reference substance name:
- Clarycet
- IUPAC Name:
- Clarycet
- Reference substance name:
- 131766-73-9
- EC Number:
- 603-508-6
- Cas Number:
- 131766-73-9
- IUPAC Name:
- 131766-73-9
- Details on test material:
- - Name of test material (as cited in study report): Clarycet
- Structural formula attached as image file (if other than submission substance): see Fig.
- Molecular weight (if other than submission substance): 200.28
- Smiles notation (if other than submission substance): C1(C)(OC(C)=O)CC(CCC)OCC1
- Physical state: Liquid
- Analytical purity: > 94 %; 45 - 60 % trans, 40 - 55 % cis.
- Lot/batch No.: 6370
- Expiration date of the lot/batch: December 1993
- Storage condition of test material: Room temperature in darkness
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd, Margate, Kent, England.
- Age at study initiation: 25 days old on dispatch
- Weight at study initiation: 22 - 24 g
- Assigned to test groups randomly: Yes
- Fasting period before study: Overnight
- Housing: In plastic disposable cages
- Diet (e.g. ad libitum): Pelleted Biosure LAD 1 rodent diet, ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: 4 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 °C
- Air changes (per hr): 30
- Photoperiod (hrs dark / hrs light): 12 hours light/dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- 1 % methylcellulose
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Suspensions/emulsions of the test substance were prepared in 1 % methylcellulose on the morning of the test. Stability and homogeneity of the test compound and of the test compound in the vehicle were not determined. Chemical analysis of dosing formulations for acheived concentration was not performed.
All groups were dosed with the standard volume of 20 mL/kg bodyweight. - Duration of treatment / exposure:
- Single administration
- Frequency of treatment:
- Single administration
- Post exposure period:
- None specified
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1080, 1800, 3000 and 5000 mg/kg
Basis:
actual ingested
Phase 1 preliminary toxicity study
- Remarks:
- Doses / Concentrations:
750, 1050, 1470 and 2058 mg/kg
Basis:
actual ingested
Phase 2 preliminary toxicity study
- Remarks:
- Doses / Concentrations:
1600 mg/kg
Basis:
actual ingested
micronucleus test
- No. of animals per sex per dose:
- 2/sex/dose in the preliminary toxicity study
15/sex/dose in the micronucleus study - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Mitomycin C was used as the positive control compound. It was prepared as a solution in 0.9 % saline at a concentration of 0.6 mg/mL just prior to administration in the preliminary toxicity study. In the micronucleus study the positive control was administered to 5 animals/sex/dose at a dosage of 12 mg/kg.
Examinations
- Tissues and cell types examined:
- The animals were examined regularly for mortalities or clinical signs of reaction.
- Details of tissue and slide preparation:
- DETAILS OF SLIDE PREPARATION:
Both femurs were dissected out from each animal. The femurs were cleared of tissue and the proximal epiphysis removed from each bone. A direct bone marrow smear was made onto a slide containing a drop of calf serum. One smear was made from each femur. The prepared smears were fixed in methanol (>10 minutes). After air-drying the smears were stained for 10 minutes in 10 % Giemsa (prepared by 1:9 dilution of Gurr's improved R66 Giemsa with distilled water). Following rinsing in distilled water and differentiation in buffered distilled water (pH 6.8), the smears were air dried and mounted with coverslips using DPX.
METHOD OF ANALYSIS:
The stained smears were examined (under code) by light microscopy to determine the incidence of micronucleated cells per 1000 polychromatic erythrocytes per animal.
The ratio of polychromatic erythrocytes for each animal was assessed by examiantion of at least 1000 erythrocytes. A record of the number of micronucleated normochromatic erythrocytes observed during assessment of this ratio was also kept. - Evaluation criteria:
- A positive response is normally indicated by a substantial, statistically significant increase in the incidence of micronucleated polychromatic erythrocytes compared to the incidence for the concurrent vehicle control group for at least one of the sampling times. In borderline cases, e.g. where individual or group mean values for not fall outside historical control ranges, further slide reading or testing may be necessary.
Boen marrow toxicity (or depression) is normally indicated by a substantial, statistically significant decrease in the ratio of polychromatic to normochromatic erythrocytes. This decrease would normally be evident at both the 48 and 72 hour sampling points, a decrease at the 24 h time point is not necessarily expected because of the relatively long transition time of erythroid cells. A very large decrease in this ratio would be indicative of a cytotoxic effect. - Statistics:
- Non-parametric statistical methods, based on rank are chosen for analysis of results because:
a) They are suited to analysis of data consisting of discrete/integer values such as the incidence of micronucleated polychromatic erythrocytes.
b) The methods make few assumptions about the underlying distribution of data and therefore the values do not require transformation to fit a theoretical distribution (where data can be approximately fitted to a normal disctribution, the results of non-parametric analysis and classical analysis of variance are very similar).
c) "Outliers" are frequently found in the polychromatic erythrocyte to normochromatic erythrocyte ratios for both control and treated animals; non-parametric analysis does not give such values an undue weighting.
For a comparison of an individual treated group with a concurrent control group, Wilcoxon's sum of ranks is used.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Two male and five female animals died after treatment with the test substance in the micronucleus test.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Clinical signs of toxicity in test animals: Two male and five female animals died after treatment with the test substance in the micronucleus test. At post mortem examination, none of the animals showed signs of misdosing. These animals were replaced by animals from the concurrently treated satellite group. No adverse clinical signs were obtained for the vehicle control or positive control treated animals over the duration of the test.
RESULTS OF DEFINITIVE STUDY
- Statistical evaluation:
The test substance did not cause any statistically significant increases in the number of micronucleated polychromatic erythrocytes at any of the three sampling times (P > 0.01 using Wilcoxon's sum of ranks test).
Mitomycin C caused large, highly significant increases (P<0.001) in the frequency of micronucleated polychromatic erythrocytes.
The test substance did not cuase any substantial increases in the incidence of micronucleated normochromatic erythrocytes at any of the three sampling times.
A small but statistically singificant decrease in the ratio of polychromatic to normochromatic erythrocytes was obtained at the 72 hour sampling time after treatment of animals with the test substance (P<0.001 using Wilcoxon' sum of ranks test). This decrease may be indicative of slight bone marrow depression induced by this relatively high acute dose of the test substance.
Mitomycin C did not cause any statistically significant decreases in the ratio (P>0.01). It should be noted that even very cytotoxic compounds such as Mitomycin C do not always produce a substantial decrease in this ratio as early as the 24 h sampling time because of the lag caused by erythrocyte maturation.
Any other information on results incl. tables
Summary of results - group totals/means for the entire experiment and results of statistical analysis
Sampling time |
Treatment |
Dose (mg/kg) |
Ratio p/n§ |
Incidence mnp |
Incidence mnn (total) |
24 h |
Vehicle control |
|
0.972 |
0.7 |
0.0 |
Test substance |
1600 |
1.077ns |
1.0ns |
0.4 |
|
Mitomycin C |
12 |
0.894ns |
39.9** |
1.3 |
|
48 h |
Vehicle control |
- |
1.171 |
0.3 |
0.2 |
Test substance |
1600 |
0.945ns |
0.9ns |
04.4 |
|
72 h |
Vehicle control |
- |
1.157 |
0.7 |
0.2 |
Test substance |
1600 |
0.754** |
1.3 |
1.5 |
p/n = Ratio of polychromatic to normchromatic erythrocytes
mnp = Number of micronucleated cells onserved per 1000 polychromatic erythrocytes
mnn = Number of micronucleated cells observed per 1000 normochromatic erythrocytes
§ Very small apparent errors of +/- 0.001 may occur in the mean p/n value due to rounding absolute p/n ratios for presentation in the tables.
Results of statistical analysis using Wilcoxon's sum of ranks test (one-side probabilities):
ns P> 0.01
* P<0.01
** P<0.001
To address toxicological endpoints as part of the REACH registration of Cineole (Target Substance) it is proposed to read-across to Clarycet (Source Substance).
The use of read-across works within the spirit of REACH and the stated aim of the legislation to reduce animal testing where possible.
The Target Substance and Source Substance have been characterised in using the categories and databases present in the OECD (Q)SAR Toolbox. From the profile, it can be seen that the two substances share structural similarities and also "mechanistic action" similarities which are both general and endpoint specific.
Therefore read-across is justified.
See Section 13 document, Read Across Justification_Clarycet
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The results of an in vivo genetic toxicity study on the structural analogue, Clarycet, are provided as part of a weight of evidence. Since the test substance did not cause any substantial increase in the incidence of micronucleated polychromatic erythrocytes, it is concluded that the test substance did not show any evidence of causing chromosome damage when administered orally in an in vivo test. - Executive summary:
This study was designed to assess the potential induction of micronuclei in bone marrow cells of mice.
Mice were treated with a single acute oral adminsitration of the test agent by intragastric gavage at a dosage of 1600 mg/kg. A preliminary toxicity test had previously shown this level to be approximately the maximum tolerated dosage.
Negative and positive control groups were dosed in an identical manner, orally by intragastric gavage. The negative control group received the vehicle, aqueous 1 % methylcellulose. The positive control group was treated with mitomycin C at 12 mg/kg bodyweight.
Bone marrow smears were obtained from five male and five female animals in the negative control and test compound groups at each of three sampling times; these being 24, 48 or 72 hours after dosing. Bone marrow smears were obtained from the positive control group 24 hours after dosing. One smear from each animal was examined for the presence of micronuclei in 1000 polychromatic erythrocytes. The ratio of polychromatic to normochromatic erythrocytes was assessed by examination of at least 1000 erythrocytes from each animal. A record of the incidence of micronucleated normochromatic erythrocytes was also kept.
At all sampling times, mice treated with the test substance did not show any signifcant increase in the frequency of micronucleated polychromatic erythrocytes.
A slight but statistically significant decrease in the ratio of polychromatic to normochromatic erythrocytes was obtained at the 72 h sampling time after treatment of the animals with the test substance. This decrease may be indicative of slight bone marrow depression induced by the test substance.
The positive control compound, mitomycin C, produced large, highly significant increases in the frequency of micronucleated polychromatic erythrocytes.
It is concluded that the test substance has not shown any evidence of causing chromosome damage in this in vivo test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.